^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    lenalidomide (STAR-LLD SC)

    i
    Other names: STAR-LLD SC, CMIO-LLD SC, Star lenalidomide programme
    Associations

    News

    Trials
    Company:
    Starton Therap
    Drug class:
    Immunomodulator
    Related drugs:
    Associations

    News

    Trials
    8ms
    Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM) (clinicaltrials.gov)
    P1/2, N=24, Recruiting, Starton Therapeutics, Inc | Trial completion date: Sep 2024 --> Mar 2027 | Trial primary completion date: Jul 2024 --> May 2026
    Trial completion date • Trial primary completion date
    |
    bortezomib • dexamethasone • lenalidomide (STAR-LLD SC)